Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us prof. dr. I.J. de Jong
University Medical Center Groningen

prof. dr. I.J. de Jong

Professor in Urology
Profile picture of prof. dr. I.J. de Jong
E-mail:
i.j.de.jong umcg.nl

Publications

Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study: Clinical Studies

Current surveillance in the Netherlands for urothelial carcinoma in lynch syndrome

Development and Validation of a Deep Learning Model Based on MRI and Clinical Characteristics to Predict Risk of Prostate Cancer Progression

Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age

Evaluation of short term surgical outcomes of radical prostatectomy in the decade following the introduction of minimum volume standards in the Netherlands

External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study

How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer?: A Multidisciplinary View

Intraoperative cone beam computed tomography for detecting residual fragments during percutaneous nephrolithotomy: one-year follow-up results from a randomized controlled trial

Intraoperative Cone Beam Computed Tomography Increases Single Procedure Stone-Free Rates in Percutaneous Nephrolithotomy: Results of a Randomized Controlled Trial

Longer-term effects of intraoperative cone-beam computed tomography in percutaneous nephrolithotomy: 18-month retrospective randomised controlled trial analysis

Press/media

Image Guided Penile Cancer Surgery (GLANS)

Cytoreductive nephrectomy and exposure to sunitinib - a post-hoc analysis of the SURTIME trial.

Prostaatcentrum Noord-Nederland krijgt eigen website

Taskforce prostaatkanker moet netwerkzorg vlot trekken